These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1525394)

  • 1. Interaction between lymphokine activated killer cells generated in the presence of cisplatin/FK-565 and tumor cells: transmission electron microscopy analysis.
    Basu S; Sodhi A
    Anticancer Drugs; 1992 Apr; 3(2):155-62. PubMed ID: 1525394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin.
    Basu S; Sodhi A; Singh SM; Suresh A
    Immunol Lett; 1991 Mar; 27(3):199-204. PubMed ID: 2060971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of IL-2 induced lymphokine activated killer cell activity by cisplatin and FK-565: involvement of calcium ion.
    Sodhi A; Basu S
    Immunol Lett; 1992 Apr; 32(2):139-46. PubMed ID: 1612637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
    Sodhi A; Basu S
    Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
    Streck RJ; Helinski EH; Ovak GM; Pauly JL
    J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565.
    Basu S; Sodhi A
    Immunol Cell Biol; 1992 Feb; 70 ( Pt 1)():15-24. PubMed ID: 1639431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
    Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
    Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
    Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells.
    Schadendorf D; Böhm M; Möller P; Grünewald T; Czarnetzki BM
    J Invest Dermatol; 1994 Jun; 102(6):838-42. PubMed ID: 8006445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells.
    Atagi S; Sone S; Fukuta K; Ogura T
    Jpn J Cancer Res; 1992 Oct; 83(10):1088-94. PubMed ID: 1452461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.
    Teichmann JV; Ludwig WD; Thiel E
    Leuk Res; 1992; 16(3):287-98. PubMed ID: 1560676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells.
    Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K
    Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM; Radcliff G; Waite R; LeFevre J; Poulik MD
    Cytometry; 1991; 12(7):666-76. PubMed ID: 1782834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury.
    Finnegan NM; Redmond HP; Bouchier-Hayes DJ
    Cancer; 1998 Jan; 82(1):186-99. PubMed ID: 9428497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of mucoid material by lymphokine-activated killer cells: study by light and electron microscopy.
    Ginsburg H; Coleman R; Davidson S; Yahav H; Khoury C
    J Leukoc Biol; 1990 May; 47(5):393-408. PubMed ID: 2186162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of human NK cells and generation of LAK activity.
    Whiteside TL
    Curr Protoc Immunol; 2001 May; Chapter 7():Unit 7.7. PubMed ID: 18432847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro.
    Nano R; Barni S; Capelli E; Cremaschi P; Catanese C; Tomaselli S; Nascimbene C; Prosperi E
    Acta Oncol; 1994; 33(2):165-9. PubMed ID: 7515629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS; Suzuki H; Yano S
    Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.